4538 — Fuso Pharmaceutical Industries Balance Sheet
0.000.00%
Last trade - 00:00
- ¥19bn
- ¥26bn
- ¥51bn
- 27
- 86
- 49
- 55
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 5,726 | 7,268 | 7,074 | 7,347 | 8,014 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 22,062 | 20,401 | 21,384 | 21,152 | 21,741 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 38,388 | 38,011 | 39,533 | 39,787 | 43,219 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 26,531 | 25,449 | 24,638 | 23,792 | 23,763 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 71,687 | 69,153 | 69,876 | 69,334 | 72,466 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 26,428 | 25,701 | 26,763 | 26,375 | 28,474 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 38,845 | 36,851 | 36,193 | 34,802 | 36,817 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 32,842 | 32,302 | 33,683 | 34,532 | 35,649 |
Total Liabilities & Shareholders' Equity | 71,687 | 69,153 | 69,876 | 69,334 | 72,466 |
Total Common Shares Outstanding |